• Je něco špatně v tomto záznamu ?

DNA and RNA Binding Proteins: From Motifs to Roles in Cancer

O. Bonczek, L. Wang, SV. Gnanasundram, S. Chen, L. Haronikova, F. Zavadil-Kokas, B. Vojtesek

. 2022 ; 23 (16) : . [pub] 20220818

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22024804

Grantová podpora
Project ENOCH; CZ.02.1.01/0.0/0.0/16_019/0000868 European Regional Development Fund
GACR 19-18177Y The Czech Science Foundation
Conceptual Development of Research Organization MMCI; 00209805 The Ministry of Health, Czech Republic
180296 and 19 0073 Pj 01 H Cancerfonden
UPD2020-0047 The Wenner-Gren Foundation in Sweden
SMK1864 Kempe foundation
LP 21-2270 Cancerforskningsfonden Norr

DNA and RNA binding proteins (DRBPs) are a broad class of molecules that regulate numerous cellular processes across all living organisms, creating intricate dynamic multilevel networks to control nucleotide metabolism and gene expression. These interactions are highly regulated, and dysregulation contributes to the development of a variety of diseases, including cancer. An increasing number of proteins with DNA and/or RNA binding activities have been identified in recent years, and it is important to understand how their activities are related to the molecular mechanisms of cancer. In addition, many of these proteins have overlapping functions, and it is therefore essential to analyze not only the loss of function of individual factors, but also to group abnormalities into specific types of activities in regard to particular cancer types. In this review, we summarize the classes of DNA-binding, RNA-binding, and DRBPs, drawing particular attention to the similarities and differences between these protein classes. We also perform a cross-search analysis of relevant protein databases, together with our own pipeline, to identify DRBPs involved in cancer. We discuss the most common DRBPs and how they are related to specific cancers, reviewing their biochemical, molecular biological, and cellular properties to highlight their functions and potential as targets for treatment.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22024804
003      
CZ-PrNML
005      
20250109080432.0
007      
ta
008      
221017s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms23169329 $2 doi
035    __
$a (PubMed)36012592
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Bonczek, Ondřej, $d 1986- $u Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute (MMCI), Zluty Kopec 7, 656 53 Brno, Czech Republic $u Department of Medical Biosciences, Umea University, 90187 Umea, Sweden $1 https://orcid.org/0000000307453136 $7 xx0327493
245    10
$a DNA and RNA Binding Proteins: From Motifs to Roles in Cancer / $c O. Bonczek, L. Wang, SV. Gnanasundram, S. Chen, L. Haronikova, F. Zavadil-Kokas, B. Vojtesek
520    9_
$a DNA and RNA binding proteins (DRBPs) are a broad class of molecules that regulate numerous cellular processes across all living organisms, creating intricate dynamic multilevel networks to control nucleotide metabolism and gene expression. These interactions are highly regulated, and dysregulation contributes to the development of a variety of diseases, including cancer. An increasing number of proteins with DNA and/or RNA binding activities have been identified in recent years, and it is important to understand how their activities are related to the molecular mechanisms of cancer. In addition, many of these proteins have overlapping functions, and it is therefore essential to analyze not only the loss of function of individual factors, but also to group abnormalities into specific types of activities in regard to particular cancer types. In this review, we summarize the classes of DNA-binding, RNA-binding, and DRBPs, drawing particular attention to the similarities and differences between these protein classes. We also perform a cross-search analysis of relevant protein databases, together with our own pipeline, to identify DRBPs involved in cancer. We discuss the most common DRBPs and how they are related to specific cancers, reviewing their biochemical, molecular biological, and cellular properties to highlight their functions and potential as targets for treatment.
650    _2
$a DNA $7 D004247
650    _2
$a DNA vazebné proteiny $x metabolismus $7 D004268
650    _2
$a lidé $7 D006801
650    12
$a nádory $x genetika $x metabolismus $7 D009369
650    _2
$a RNA $x genetika $7 D012313
650    12
$a proteiny vázající RNA $x metabolismus $7 D016601
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Wang, Lixiao $u Department of Medical Biosciences, Umea University, 90187 Umea, Sweden
700    1_
$a Gnanasundram, Sivakumar Vadivel $u Department of Medical Biosciences, Umea University, 90187 Umea, Sweden $1 https://orcid.org/0000000191530784
700    1_
$a Chen, Sa $u Department of Medical Biosciences, Umea University, 90187 Umea, Sweden
700    1_
$a Haronikova, Lucia $u Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute (MMCI), Zluty Kopec 7, 656 53 Brno, Czech Republic
700    1_
$a Zavadil-Kokas, Filip $u Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute (MMCI), Zluty Kopec 7, 656 53 Brno, Czech Republic
700    1_
$a Vojtesek, Borivoj $u Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute (MMCI), Zluty Kopec 7, 656 53 Brno, Czech Republic $1 https://orcid.org/0000000161943705
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 23, č. 16 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36012592 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20250109080427 $b ABA008
999    __
$a ok $b bmc $g 1854501 $s 1176094
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 23 $c 16 $e 20220818 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a Project ENOCH; CZ.02.1.01/0.0/0.0/16_019/0000868 $p European Regional Development Fund
GRA    __
$a GACR 19-18177Y $p The Czech Science Foundation
GRA    __
$a Conceptual Development of Research Organization MMCI; 00209805 $p The Ministry of Health, Czech Republic
GRA    __
$a 180296 and 19 0073 Pj 01 H $p Cancerfonden
GRA    __
$a UPD2020-0047 $p The Wenner-Gren Foundation in Sweden
GRA    __
$a SMK1864 $p Kempe foundation
GRA    __
$a LP 21-2270 $p Cancerforskningsfonden Norr
LZP    __
$a Pubmed-20221017

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...